Literature DB >> 33429783

Therapy of diarrhea in COVID-19 with external treatment of traditional Chinese medicine: A protocol for systematic review and meta-analysis.

Cheng Cheng1, Yashuang Huang, Li Xie, Xinghui Zhu, Dongmei Chen, Cisong Cheng.   

Abstract

BACKGROUND: Evaluating the effectiveness and safety of external treatment of traditional Chinese medicine therapy for COVID-19 with diarrhea is the primary purpose of this systematic evaluation program.
METHODS: We will search the randomized controlled trials from inception to November 2020. The following database is our focus area: Cochrane Central Register of Controlled Trials, Embase, PubMed, Web of Science, China National Knowledge Infrastructure (CNKI), Chinese Biomedical Database (CBM), VIP database for Chinese technical Periodicals, and Wanfang Database. We will choose articles published both in Chinese and English. Two reviewers will conduct the study selection, data extraction, and assessment independently. The assessment of risk of bias and data synthesis will be carried out using Review Manager Software V.5.3.
RESULTS: The results will provide high-quality synthesis of current evidence for researchers in this subject area.
CONCLUSION: This studys decision will provide evidence of whether external treatment of traditional Chinese medicine is an effective and safe intervention for coronavirus disease 2019 with diarrhea. REGISTRATION NUMBER: INPLASY2020110095 (DOI number: 10.37766/inplasy2020.11.0095).
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33429783      PMCID: PMC7793404          DOI: 10.1097/MD.0000000000024120

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  10 in total

1.  Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

Authors:  Dawei Wang; Bo Hu; Chang Hu; Fangfang Zhu; Xing Liu; Jing Zhang; Binbin Wang; Hui Xiang; Zhenshun Cheng; Yong Xiong; Yan Zhao; Yirong Li; Xinghuan Wang; Zhiyong Peng
Journal:  JAMA       Date:  2020-03-17       Impact factor: 56.272

Review 2.  Covid-19 and the digestive system.

Authors:  Sunny H Wong; Rashid Ns Lui; Joseph Jy Sung
Journal:  J Gastroenterol Hepatol       Date:  2020-04-19       Impact factor: 4.029

3.  Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation.

Authors:  Larissa Shamseer; David Moher; Mike Clarke; Davina Ghersi; Alessandro Liberati; Mark Petticrew; Paul Shekelle; Lesley A Stewart
Journal:  BMJ       Date:  2015-01-02

4.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

5.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study.

Authors:  Nanshan Chen; Min Zhou; Xuan Dong; Jieming Qu; Fengyun Gong; Yang Han; Yang Qiu; Jingli Wang; Ying Liu; Yuan Wei; Jia'an Xia; Ting Yu; Xinxin Zhang; Li Zhang
Journal:  Lancet       Date:  2020-01-30       Impact factor: 79.321

Review 6.  An overview of COVID-19.

Authors:  Yu Shi; Gang Wang; Xiao-Peng Cai; Jing-Wen Deng; Lin Zheng; Hai-Hong Zhu; Min Zheng; Bo Yang; Zhi Chen
Journal:  J Zhejiang Univ Sci B       Date:  2020-05-08       Impact factor: 3.066

7.  Diarrhea During COVID-19 Infection: Pathogenesis, Epidemiology, Prevention, and Management.

Authors:  Ferdinando D'Amico; Daniel C Baumgart; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Clin Gastroenterol Hepatol       Date:  2020-04-08       Impact factor: 11.382

Review 8.  COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms.

Authors:  Peijie Zhong; Jing Xu; Dong Yang; Yue Shen; Lu Wang; Yun Feng; Chunling Du; Yuanlin Song; Chaomin Wu; Xianglin Hu; Yangbai Sun
Journal:  Signal Transduct Target Ther       Date:  2020-11-02

Review 9.  COVID-19 extrapulmonary illness - special gastrointestinal and hepatic considerations.

Authors:  Abhilash Perisetti; Mahesh Gajendran; Rupinder Mann; Sherif Elhanafi; Hemant Goyal
Journal:  Dis Mon       Date:  2020-07-28       Impact factor: 3.800

Review 10.  SARS-CoV-2: an Emerging Coronavirus that Causes a Global Threat.

Authors:  Jun Zheng
Journal:  Int J Biol Sci       Date:  2020-03-15       Impact factor: 6.580

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.